drugset
drugset / Trial / NCT02139033

A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome

NCT02139033 ↗

Phase 4 Completed 42 enrolled Ocusoft, Inc. ORA, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the efficacy of Retaine™ ophthalmic emulsion in treating the signs and symptoms of dry eye syndrome.

Timeline

Start
2014-05
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Retaine Unknown — Topical

Indications

dry eye syndrome